Account wins from 09/09 News Brief

Share this article:
InChord Communications has been selected to develop and implement the marketing strategy for two new products from nutraceuticals firm Millennium Biotechnologies. InChord will handle U.S. launch of Resurgex and Resurgex-Plus.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.